Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica

Amebiasis caused by Entamoeba histolytica is the third leading cause of parasitic mortality globally, with some 100,000 deaths annually, primarily among young children. Protective immunity to amebiasis is associated with fecal IgA and IFN-γ in humans; however, no vaccine exists. We have previously i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:NPJ Vaccines
Autors principals: Abhyankar, Mayuresh M., Orr, Mark T., Lin, Susan, Suraju, Mohammed O., Simpson, Adrian, Blust, Molly, Pham, Tiep, Guderian, Jeffrey A., Tomai, Mark A., Elvecrog, James, Pedersen, Karl, Petri, William A., Fox, Christopher B.
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2018
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5988657/
https://ncbi.nlm.nih.gov/pubmed/29900011
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41541-018-0060-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars